Home / Publications / Pain Research Forum / Papers of the Week / A randomized, observer-blind, vehicle-control, multi-center clinical investigation for assessing the efficacy and tolerability of a 1% ectoine and hyaluronic acid 0.1%-containing medical device in pediatric patients with mild-to-moderate atopic dermatitis
A randomized, observer-blind, vehicle-control, multi-center clinical investigation for assessing the efficacy and tolerability of a 1% ectoine and hyaluronic acid 0.1%-containing medical device in pediatric patients with mild-to-moderate atopic dermatitis
Alexopoulos A, Dakoutrou M, Nasi L, Thanopoulou I, Kakourou T, Kontara L, Douladiris N, Galani M, Xepapadaki P, Doxani C, Mprotsis T, Zintzaras E, Papadopoulos NG, Kanaka-Gantenbein C, Chrousos GP
Ectoine is a widespread osmolyte enabling halophilic bacteria to withstand high osmotic stress that has many potential applications ranging from cosmetics to its use as a therapeutic agent.
